Exogenous Cushing Syndrome pada Kasus Systemic Lupus Erythematosus
KOLONI · 18.06.2026 · 5 (2) · 314-322
DOI: 10.31004/koloni.v5i2.895 ↗Kurz gefasst
Fachartikel in der Zeitschrift KOLONI, online erschienen am 18.06.2026. Verfasst von I Gusti Agung Ayu Indrayuni und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).
Abstract (Originalsprache)
Cushing's syndrome (CS) is a group of signs and symptoms caused by chronic exposure to excess glucocorticoids. There are two types of Cushing's syndrome, endogenous and exogenous. Exogenous Cushing's syndrome, is a consequence of prolonged exposure to glucocorticoid drugs. Hypercortisolism is characterized by specific clinical features (moon face, facial plethora, striae rubrae, and supraclavicular and dorsal fat pads), as well as metabolic complications such as visceral obesity, hypertension, diabetes, dyslipidemia, osteoporosis, and detrimental effects on the brain, including hippocampal damage and memory impairment. Exogenous Cushing's syndrome is characterized by low serum cortisol levels in the morning. Discontinuation of exogenous glucocorticoids is the main pillar that must be carried out in exogenous Cushing's syndrome
Zitieren
APA
Indrayuni, I. G. A. A., Gotera, W., & Nugraha, I. B. A. (2026). Exogenous Cushing Syndrome pada Kasus Systemic Lupus Erythematosus. KOLONI, 5(2), 314-322. https://doi.org/10.31004/koloni.v5i2.895
Vancouver
Indrayuni IGAA, Gotera W, Nugraha IBA. Exogenous Cushing Syndrome pada Kasus Systemic Lupus Erythematosus. KOLONI. 2026;5(2):314-322. doi:10.31004/koloni.v5i2.895
BibTeX
@article{Indrayuni2026,
author = {Indrayuni, I Gusti Agung Ayu and Gotera, Wira and Nugraha, Ida Bagus Aditya},
title = {Exogenous Cushing Syndrome pada Kasus Systemic Lupus Erythematosus},
journal = {KOLONI},
year = {2026},
volume = {5},
number = {2},
pages = {314--322},
doi = {10.31004/koloni.v5i2.895}
}
EUVIMED